Back to HighTower Advisors, LLC HighTower Advisors, LLC

INBXINBX
8 quarters

Position history for HighTower Advisors, LLCHighTower Advisors, LLC's holdings in INHIBRX BIOSCIENCES INC

HighTower Advisors, LLC holds 870,200 shares of INBX (INHIBRX BIOSCIENCES INC), worth $58.5M as of 2026-Q1. The position was decreased (-0.0% shares). INBX represents 0.1% of HighTower Advisors, LLC's portfolio.

Current Value

$58.5M

Current Shares

870,200

Total Value Change

+$57M

Total Shares Change

+762,700

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
870,200
-0.0%
$58.5M0.1%$74.33
0
2025-Q4
Decreased
870,507
-0.1%
$68.8M0.1%$77.98
0
2025-Q3
Unchanged
871,759
0.0%
$29.4M0.0%$32.31
0
2025-Q2
Increased
871,759
0.0%
$12.4M0.0%$14.43
28
2025-Q1
Increased
871,754
+11.5%
$12.2M0.0%$14.12
31
2024-Q4
Increased
781,752
+538.2%
$12M0.0%$15.14
45
2024-Q3
Increased
122,500
+13.9%
$1.9M0.0%$15.52
29
2024-Q2
New
107,500
-
$1.5M0.0%$14.17
35

Other major holders of INBX: VIKING GLOBAL INVESTORS LP, MORGAN STANLEY, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used